Europe's only event to focus on budgeting, forecasting and cost management clinical trials!
By attending you will gain:
Insight into the current techniques and methods available to ensure that your clinical trial costs are kept to a minimum
Improved understanding in how to make the most of your clinical trial resources in the current financial climate with key methods for improving the forecast of clinical trials
The knowledge to ensure you have a successful budget plan in place by learning how to identify and predict costs related to your clinical trial
2012 Agenda Highlights
Identify the specific challenges related to clinical trial budgeting, including the key costs pressures, integrating the trial budget within the corporate budget, budget close and the pitfalls of longer term budget planning
Review the accuracy and improvements necessary for budget forecasting: Hear from Grunenthal and Bayer on their experiences with purpose built forecasting and management tools, and how to extract more value from existing forecasting tools with Novartis
Explore the value of external benchmarking databases with Eli Lilly & Company and the advances that may be made in the future
Understand the current challenges in budgeting and cost management within a strategic partnerships and assess the budgetary drives for forming these relationships, with experiences from GlaxoSmithKline, Biogen Idec and Johnson & Johnson
Gain the tools to enhance your internal and external budget negotiations by attending the pre-conference negotiations workshop
Homepage speakers
Homepage speakers
Pasi PiitulainenSenior Director Business & Science AffairsActelion
Keith BorkettDirector, Clinical Operations DepartmentPAION
Michael HerschelDirector, Clinical ResearchGlaxoSmithKline
Anja PietschResource Manager, GCD Operations & Resource ManagementBayer Pharma AG
Ann MarinusAssistant Director, Project & Budget Development DepartmentEuropean Organization for Research & Treatment of Cancer